Skip to main content
Top
Published in: Endocrine 1/2019

Open Access 01-07-2019 | Insulins | Original Article

Decreased deiodinase activity after glucose load could lead to atherosclerosis in euthyroid women with polycystic ovary syndrome

Authors: Agnieszka Adamska, Anna Krentowska, Agnieszka Łebkowska, Justyna Hryniewicka, Monika Leśniewska, Marcin Adamski, Irina Kowalska

Published in: Endocrine | Issue 1/2019

Login to get access

Abstract

Objective

Glucose and lipid disturbances, as well as higher tendency to atherosclerosis, are observed in women with polycystic ovary syndrome (PCOS). Thyroid hormones action has long been recognized as an important determinant of glucose and lipid homeostasis. Some studies suggest that even in euthyroid subjects, thyroid function may affect atherosclerosis risk factors. The aim of this study was to evaluate the relationships between thyroid hormonal status and glucose and lipid profile before and after oral glucose tolerance test (OGTT) in PCOS women in comparison to the control group.

Patients and methods

The study group included 98 women—60 women with PCOS and 38 women matched for age and BMI as a control group. OGTT with estimation of plasma glucose and lipids, as well as serum insulin and thyroid hormones (TH) concentrations was performed. Activity of peripheral deiodinases at baseline (SPINA-GD1) and at the 120 min of OGTT (SPINA-GD2) was calculated according to the formula by Dietrich et al. as a measure of T4–T3 conversion efficiency. Delta GD was estimated as SPINA-GD1–SPINA-GD2, and delta fT3 was calculated as a difference between fT3 before and after OGTT.

Results

We did not find differences in TH, SPINA-GDs, and plasma lipid concentrations between PCOS and control group before and after OGTT. Glucose load resulted in a decrease of level TSH, TC, TG, HDL-C, and LDL-C concentrations in women with PCOS, as well as in the control group (all p < 0.05). We found that GD (p = 0.01) and serum fT3 concentration (p = 0.0008) decreased during glucose load only in the PCOS group. We observed a positive relationship between delta fT3 and plasma TG concentration (r = 0.36, p = 0.004), delta GD and plasma TG concentration after glucose load (r = 0.34, p = 0.007), only in the PCOS group. We also found negative relationship between SPINA-GD2 and plasma TC concentration (r = −0.29, p = 0.02) after glucose load and positive relationship between delta GD and insulin at the 60 min of OGTT (r = 0.29, p = 0.02), only in the PCOS women.

Conclusions

These data showed insufficient conversion of fT4 to fT3, as well as a relationship of SPINA-GDs with insulin, TC and TG in PCOS women after glucose load. It may suggest that disturbances in deiodinase activity after glucose load might promote atherosclerosis in PCOS women.
Literature
1.
go back to reference H.F. Escobar-Morreale, Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat. Rev. Endocrinol. 14, 270–284 (2018)CrossRefPubMed H.F. Escobar-Morreale, Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat. Rev. Endocrinol. 14, 270–284 (2018)CrossRefPubMed
2.
go back to reference S. Livadas, E. Diamanti-Kandarakis, Polycystic ovary syndrome: definitions, phenotypes and diagnostic approach. Front. Horm. Res. 40, 1–21 (2013)PubMed S. Livadas, E. Diamanti-Kandarakis, Polycystic ovary syndrome: definitions, phenotypes and diagnostic approach. Front. Horm. Res. 40, 1–21 (2013)PubMed
3.
go back to reference G. Papadakis, E. Kandaraki, O. Papalou, A. Vryonidou, E. Diamanti-Kandarakis, Is cardiovascular risk in women with PCOS a real risk? Current insights. Minerva Endocrinol. 42, 340–355 (2017)PubMed G. Papadakis, E. Kandaraki, O. Papalou, A. Vryonidou, E. Diamanti-Kandarakis, Is cardiovascular risk in women with PCOS a real risk? Current insights. Minerva Endocrinol. 42, 340–355 (2017)PubMed
4.
go back to reference R.A. Wild, E. Carmina, E. Diamanti-Kandarakis, A. Dokras, H.F. Escobar-Morreale, W. Futterweit et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J. Clin. Endocrinol. Metab. 95, 2038–2049 (2010)CrossRefPubMed R.A. Wild, E. Carmina, E. Diamanti-Kandarakis, A. Dokras, H.F. Escobar-Morreale, W. Futterweit et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J. Clin. Endocrinol. Metab. 95, 2038–2049 (2010)CrossRefPubMed
5.
go back to reference M. Jacewicz-Święcka, I. Kowalska, Polycystic ovary syndrome and the risk of cardiometabolic complications in longitudinal studies. Diabetes Metab. Res. Rev. 34, e3054 (2018)CrossRefPubMed M. Jacewicz-Święcka, I. Kowalska, Polycystic ovary syndrome and the risk of cardiometabolic complications in longitudinal studies. Diabetes Metab. Res. Rev. 34, e3054 (2018)CrossRefPubMed
7.
go back to reference O. Bakker, F. Hudig, S. Meijssen, W.M. Wiersinga, Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene. Biochem. Biophys. Res. Commun. 249, 517–521 (1998)CrossRefPubMed O. Bakker, F. Hudig, S. Meijssen, W.M. Wiersinga, Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene. Biochem. Biophys. Res. Commun. 249, 517–521 (1998)CrossRefPubMed
8.
go back to reference J.L. Leonard, S.A. Mellen, P.R. Larsen, Thyroxine 5′-deiodinase activity in brown adipose tissue. Endocrinology 112, 1153–1155 (1983)CrossRefPubMed J.L. Leonard, S.A. Mellen, P.R. Larsen, Thyroxine 5′-deiodinase activity in brown adipose tissue. Endocrinology 112, 1153–1155 (1983)CrossRefPubMed
9.
go back to reference J.M. Bates, D.L. St Germain, V.A. Galton, Expression profiles of the three iodothyronine deiodinases, D1, D2, and D3, in the developing rat. Endocrinology 140, 844–851 (1999)CrossRefPubMed J.M. Bates, D.L. St Germain, V.A. Galton, Expression profiles of the three iodothyronine deiodinases, D1, D2, and D3, in the developing rat. Endocrinology 140, 844–851 (1999)CrossRefPubMed
10.
go back to reference D. Salvatore, S.C. Low, M. Berry, A.L. Maia, J.W. Harney, W. Croteau et al. Type 3 lodothyronine deiodinase: cloning, in vitro expression, and functional analysis of the placental selenoenzyme. J. Clin. Invest. 96, 2421–2430 (1995)CrossRefPubMedPubMedCentral D. Salvatore, S.C. Low, M. Berry, A.L. Maia, J.W. Harney, W. Croteau et al. Type 3 lodothyronine deiodinase: cloning, in vitro expression, and functional analysis of the placental selenoenzyme. J. Clin. Invest. 96, 2421–2430 (1995)CrossRefPubMedPubMedCentral
11.
go back to reference B. Gereben, A.M. Zavacki, S. Ribich, B.W. Kim, S.A. Huang, W.S. Simonides et al. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr. Rev. 29, 898–938 (2008)CrossRefPubMedPubMedCentral B. Gereben, A.M. Zavacki, S. Ribich, B.W. Kim, S.A. Huang, W.S. Simonides et al. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr. Rev. 29, 898–938 (2008)CrossRefPubMedPubMedCentral
12.
go back to reference E. Gałecka, A. Kumor-Kisielewska, A. Orzechowska, M. Maes, P. Górski, J. Szemraj, Assessment of type 1 and type 3 deiodinase expression levels in depressive disorders. Acta Neurobiol. Exp. 77, 225–235 (2017) E. Gałecka, A. Kumor-Kisielewska, A. Orzechowska, M. Maes, P. Górski, J. Szemraj, Assessment of type 1 and type 3 deiodinase expression levels in depressive disorders. Acta Neurobiol. Exp. 77, 225–235 (2017)
13.
go back to reference S.L. Goede, M.K. Leow, J.W. Smit, J.W. Dietrich, A novel minimal mathematical model of the hypothalamus-pituitary-thyroid axis validated for individualized clinical applications. Math. Biosci. 249, 1–7 (2014)CrossRefPubMed S.L. Goede, M.K. Leow, J.W. Smit, J.W. Dietrich, A novel minimal mathematical model of the hypothalamus-pituitary-thyroid axis validated for individualized clinical applications. Math. Biosci. 249, 1–7 (2014)CrossRefPubMed
14.
go back to reference S.L. Goede, M.K. Leow, J.W. Smit, H.H. Klein, J.W. Dietrich, Hypothalamus-pituitary-thyroid feedback control: implications of mathematical modeling and consequences for thyrotropin (TSH) and free thyroxine (FT4) reference ranges. Bull. Math. Biol. 76, 1270–1287 (2014)CrossRefPubMed S.L. Goede, M.K. Leow, J.W. Smit, H.H. Klein, J.W. Dietrich, Hypothalamus-pituitary-thyroid feedback control: implications of mathematical modeling and consequences for thyrotropin (TSH) and free thyroxine (FT4) reference ranges. Bull. Math. Biol. 76, 1270–1287 (2014)CrossRefPubMed
15.
go back to reference J.W. Dietrich, G. Landgrafe-Mende, E. Wiora, A. Chatzitomaris, H.H. Klein, J.E. Midgley et al. Calculated parameters of thyroid homeostasis: emerging tools for differential diagnosis and clinical research. Front. Endocrinol. 7, 57 (2016)CrossRef J.W. Dietrich, G. Landgrafe-Mende, E. Wiora, A. Chatzitomaris, H.H. Klein, J.E. Midgley et al. Calculated parameters of thyroid homeostasis: emerging tools for differential diagnosis and clinical research. Front. Endocrinol. 7, 57 (2016)CrossRef
16.
go back to reference I. Kowalska, M. Straczkowski, A. Nikolajuk, A. Adamska, M. Karczewska-Kupczewska, E. Otziomek et al. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Hum. Reprod. 22, 1824–1829 (2007)CrossRefPubMed I. Kowalska, M. Straczkowski, A. Nikolajuk, A. Adamska, M. Karczewska-Kupczewska, E. Otziomek et al. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Hum. Reprod. 22, 1824–1829 (2007)CrossRefPubMed
17.
go back to reference A. Vermeulen, L. Verdonck, J.M. Kaufman, A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84, 3666–3672 (1999)CrossRefPubMed A. Vermeulen, L. Verdonck, J.M. Kaufman, A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84, 3666–3672 (1999)CrossRefPubMed
18.
go back to reference A. Adamska, A. Łebkowska, A. Krentowska, M. Jacewicz, M. Górska, I. Kowalska, Relationship between serum gonadotropin concentrations and thyroid volume in women with polycystic ovary syndrome. Pol. Arch. Med. Wewn. 126, 891–894 (2016)PubMed A. Adamska, A. Łebkowska, A. Krentowska, M. Jacewicz, M. Górska, I. Kowalska, Relationship between serum gonadotropin concentrations and thyroid volume in women with polycystic ovary syndrome. Pol. Arch. Med. Wewn. 126, 891–894 (2016)PubMed
19.
go back to reference D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985)CrossRef D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985)CrossRef
20.
go back to reference J.W. Dietrich, A. Stachon, B. Antic, H.H. Klein, S. Hering, The AQUA-FONTIS study: protocol of a multidisciplinary, cross-sectional and prospective longitudinal study for developing standardized diagnostics and classification of non-thyroidal illness syndrome. BMC Endocr. Disord. 8, 13 (2008)CrossRefPubMedPubMedCentral J.W. Dietrich, A. Stachon, B. Antic, H.H. Klein, S. Hering, The AQUA-FONTIS study: protocol of a multidisciplinary, cross-sectional and prospective longitudinal study for developing standardized diagnostics and classification of non-thyroidal illness syndrome. BMC Endocr. Disord. 8, 13 (2008)CrossRefPubMedPubMedCentral
21.
go back to reference J. Brunn, U. Block, G. Ruf, I. Bos, W.P. Kunze, P.C. Scriba, Volumetric analysis of thyroid lobes by real-time ultrasound (author’s transl). Dtsch. Med. Wochenschr. 106, 1338–1340 (1981)CrossRefPubMed J. Brunn, U. Block, G. Ruf, I. Bos, W.P. Kunze, P.C. Scriba, Volumetric analysis of thyroid lobes by real-time ultrasound (author’s transl). Dtsch. Med. Wochenschr. 106, 1338–1340 (1981)CrossRefPubMed
22.
go back to reference A.C. Bianco, G. Anderson, D. Forrest, V.A. Galton, B. Gereben, B.W. Kim et al. American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models. Thyroid 24, 88–168 (2014)CrossRefPubMedPubMedCentral A.C. Bianco, G. Anderson, D. Forrest, V.A. Galton, B. Gereben, B.W. Kim et al. American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models. Thyroid 24, 88–168 (2014)CrossRefPubMedPubMedCentral
23.
go back to reference A. Jabbar, A. Pingitore, S.H. Pearce, A. Zaman, G. Iervasi, S. Razvi, Thyroid hormones and cardiovascular disease. Nat. Rev. Cardiol. 14, 39–55 (2017)CrossRefPubMed A. Jabbar, A. Pingitore, S.H. Pearce, A. Zaman, G. Iervasi, S. Razvi, Thyroid hormones and cardiovascular disease. Nat. Rev. Cardiol. 14, 39–55 (2017)CrossRefPubMed
24.
go back to reference A. Marsili, C. Aguayo-Mazzucato, T. Chen, A. Kumar, M. Chung, E.P. Lunsford et al. Mice with a targeted deletion of the type 2 deiodinase are insulin resistant and susceptible to diet induced obesity. PLoS One 6, e20832 (2011)CrossRefPubMedPubMedCentral A. Marsili, C. Aguayo-Mazzucato, T. Chen, A. Kumar, M. Chung, E.P. Lunsford et al. Mice with a targeted deletion of the type 2 deiodinase are insulin resistant and susceptible to diet induced obesity. PLoS One 6, e20832 (2011)CrossRefPubMedPubMedCentral
25.
go back to reference E. Akarsu, H. Korkmaz, S. Oguzkan Balci, E. Borazan, S. Korkmaz, M. Tarakcioglu, Subcutaneous adipose tissue type II deiodinase gene expression reduced in obese individuals with metabolic syndrome. Exp. Clin. Endocrinol. Diabetes 124, 11–15 (2016)PubMed E. Akarsu, H. Korkmaz, S. Oguzkan Balci, E. Borazan, S. Korkmaz, M. Tarakcioglu, Subcutaneous adipose tissue type II deiodinase gene expression reduced in obese individuals with metabolic syndrome. Exp. Clin. Endocrinol. Diabetes 124, 11–15 (2016)PubMed
26.
go back to reference D. Mentuccia, M.J. Thomas, G. Coppotelli, L.J. Reinhart, B.D. Mitchell, A.R. Shuldiner et al. The Thr92Ala deiodinase type 2 (DIO2) variant is not associated with type 2 diabetes or indices of insulin resistance in the old order of Amish. Thyroid 15, 1223–1227 (2005)CrossRefPubMed D. Mentuccia, M.J. Thomas, G. Coppotelli, L.J. Reinhart, B.D. Mitchell, A.R. Shuldiner et al. The Thr92Ala deiodinase type 2 (DIO2) variant is not associated with type 2 diabetes or indices of insulin resistance in the old order of Amish. Thyroid 15, 1223–1227 (2005)CrossRefPubMed
27.
go back to reference L.H. Canani, C. Capp, J.M. Dora, E.L. Meyer, M.S. Wagner, J.W. Harney et al. The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 90, 3472–3478 (2005)CrossRefPubMed L.H. Canani, C. Capp, J.M. Dora, E.L. Meyer, M.S. Wagner, J.W. Harney et al. The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 90, 3472–3478 (2005)CrossRefPubMed
28.
go back to reference J.M. Dora, W.E. Machado, J. Rheinheimer, D. Crispim, A.L. Maia, Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case-control study and meta-analysis. Eur. J. Endocrinol. 163, 427–434 (2010)CrossRefPubMed J.M. Dora, W.E. Machado, J. Rheinheimer, D. Crispim, A.L. Maia, Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case-control study and meta-analysis. Eur. J. Endocrinol. 163, 427–434 (2010)CrossRefPubMed
29.
go back to reference R.P. Peeters, A.W. van den Beld, H. van Toor, A.G. Uitterlinden, J.A. Janssen, S.W. Lamberts et al. A polymorphism in type I deiodinase is associated with circulating free insulin-like growth factor I levels and body composition in humans. J. Clin. Endocrinol. Metab. 90, 256–263 (2005)CrossRefPubMed R.P. Peeters, A.W. van den Beld, H. van Toor, A.G. Uitterlinden, J.A. Janssen, S.W. Lamberts et al. A polymorphism in type I deiodinase is associated with circulating free insulin-like growth factor I levels and body composition in humans. J. Clin. Endocrinol. Metab. 90, 256–263 (2005)CrossRefPubMed
30.
go back to reference F.J. de Jong, R.P. Peeters, T. den Heijer, W.M. van der Deure, A. Hofman, A.G. Uitterlinden et al. The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe. J. Clin. Endocrinol. Metab. 92, 636–640 (2007)CrossRefPubMed F.J. de Jong, R.P. Peeters, T. den Heijer, W.M. van der Deure, A. Hofman, A.G. Uitterlinden et al. The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe. J. Clin. Endocrinol. Metab. 92, 636–640 (2007)CrossRefPubMed
31.
go back to reference A. Chatzitomaris, R. Hoermann, J.E. Midgley, S. Hering, A. Urban, B. Dietrich et al. Thyroid allostasis-adaptive responses of thyrotropic feedback control to conditions of strain, stress, and developmental programming. Front. Endocrinol. 8, 163 (2017)CrossRef A. Chatzitomaris, R. Hoermann, J.E. Midgley, S. Hering, A. Urban, B. Dietrich et al. Thyroid allostasis-adaptive responses of thyrotropic feedback control to conditions of strain, stress, and developmental programming. Front. Endocrinol. 8, 163 (2017)CrossRef
32.
33.
go back to reference K. Ogita, M. Ai, A. Tanaka, Y. Ito, T. Hirano, G. Yoshino et al. Serum concentration of small dense low-density lipoprotein-cholesterol during oral glucose tolerance test and oral fat tolerance test. Clin. Chim. Acta 387, 36–41 (2008)CrossRefPubMed K. Ogita, M. Ai, A. Tanaka, Y. Ito, T. Hirano, G. Yoshino et al. Serum concentration of small dense low-density lipoprotein-cholesterol during oral glucose tolerance test and oral fat tolerance test. Clin. Chim. Acta 387, 36–41 (2008)CrossRefPubMed
34.
go back to reference E. Ortega, J. Koska, N. Pannacciulli, J.C. Bunt, J. Krakoff, Free triiodothyronine plasma concentrations are positively associated with insulin secretion in euthyroid individuals. Eur. J. Endocrinol. 158, 217–221 (2008)CrossRefPubMedPubMedCentral E. Ortega, J. Koska, N. Pannacciulli, J.C. Bunt, J. Krakoff, Free triiodothyronine plasma concentrations are positively associated with insulin secretion in euthyroid individuals. Eur. J. Endocrinol. 158, 217–221 (2008)CrossRefPubMedPubMedCentral
35.
go back to reference M. Moreno, E. Silvestri, R. De Matteis, P. de Lange, A. Lombardi, D. Glinni et al. 3,5-Diiodo-l-thyronine prevents high-fat-diet-induced insulin resistance in rat skeletal muscle through metabolic and structural adaptations. FASEB J. 25, 3312–3324 (2011)CrossRefPubMed M. Moreno, E. Silvestri, R. De Matteis, P. de Lange, A. Lombardi, D. Glinni et al. 3,5-Diiodo-l-thyronine prevents high-fat-diet-induced insulin resistance in rat skeletal muscle through metabolic and structural adaptations. FASEB J. 25, 3312–3324 (2011)CrossRefPubMed
36.
go back to reference Y. Lin, Z. Sun, Thyroid hormone potentiates insulin signaling and attenuates hyperglycemia and insulin resistance in a mouse model of type 2 diabetes. Br. J. Pharmacol. 162, 597–610 (2011)CrossRefPubMedPubMedCentral Y. Lin, Z. Sun, Thyroid hormone potentiates insulin signaling and attenuates hyperglycemia and insulin resistance in a mouse model of type 2 diabetes. Br. J. Pharmacol. 162, 597–610 (2011)CrossRefPubMedPubMedCentral
37.
go back to reference G. Dimitriadis, P. Mitrou, V. Lambadiari, E. Boutati, E. Maratou, D.B. Panagiotakos et al. Insulin action in adipose tissue and muscle in hypothyroidism. J. Clin. Endocrinol. Metab. 91, 4930–4937 (2006)CrossRefPubMed G. Dimitriadis, P. Mitrou, V. Lambadiari, E. Boutati, E. Maratou, D.B. Panagiotakos et al. Insulin action in adipose tissue and muscle in hypothyroidism. J. Clin. Endocrinol. Metab. 91, 4930–4937 (2006)CrossRefPubMed
38.
go back to reference P. Langer, E. Martino, L. Ksinantova, L. Glasso, M. Vigas, Changes of serum TSH level during oral glucose tolerance test: comparison of morning and evening test with plain circadian TSH rhythm. Endocr. Regul. 34, 145–150 (2000)PubMed P. Langer, E. Martino, L. Ksinantova, L. Glasso, M. Vigas, Changes of serum TSH level during oral glucose tolerance test: comparison of morning and evening test with plain circadian TSH rhythm. Endocr. Regul. 34, 145–150 (2000)PubMed
39.
go back to reference G. De Pergola, A. Ciampolillo, S. Paolotti, P. Trerotoli, R. Giorgino, Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin. Endocrinol. 67, 265–269 (2007)CrossRef G. De Pergola, A. Ciampolillo, S. Paolotti, P. Trerotoli, R. Giorgino, Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin. Endocrinol. 67, 265–269 (2007)CrossRef
40.
go back to reference C.M. Kitahara, E.A. Platz, P.W. Ladenson, A.M. Mondul, A. Menke, A. Berrington de González, Body fatness and markers of thyroid function among U.S. men and women. PLoS One 7, e34979 (2012)CrossRefPubMedPubMedCentral C.M. Kitahara, E.A. Platz, P.W. Ladenson, A.M. Mondul, A. Menke, A. Berrington de González, Body fatness and markers of thyroid function among U.S. men and women. PLoS One 7, e34979 (2012)CrossRefPubMedPubMedCentral
41.
go back to reference C. Dall’Asta, M. Paganelli, A. Morabito, P. Vedani, M. Barbieri, G. Paolisso et al. Weight loss through gastric banding: effects on TSH and thyroid hormones in obese subjects with normal thyroid function. Obesity 18,854–857 (2010)CrossRefPubMed C. Dall’Asta, M. Paganelli, A. Morabito, P. Vedani, M. Barbieri, G. Paolisso et al. Weight loss through gastric banding: effects on TSH and thyroid hormones in obese subjects with normal thyroid function. Obesity 18,854–857 (2010)CrossRefPubMed
Metadata
Title
Decreased deiodinase activity after glucose load could lead to atherosclerosis in euthyroid women with polycystic ovary syndrome
Authors
Agnieszka Adamska
Anna Krentowska
Agnieszka Łebkowska
Justyna Hryniewicka
Monika Leśniewska
Marcin Adamski
Irina Kowalska
Publication date
01-07-2019
Publisher
Springer US
Published in
Endocrine / Issue 1/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-01913-0

Other articles of this Issue 1/2019

Endocrine 1/2019 Go to the issue